amfAR Faces Funding Challenges Amidst Trump Administration Cuts to HIV/AIDS Programs
amfAR, a leading organization in HIV/AIDS research, is facing significant challenges due to funding cuts from the Trump administration. These cuts have affected both domestic and international HIV/AIDS research, treatment, and prevention efforts. Despite these setbacks, amfAR remains committed to finding a cure for HIV/AIDS. The organization relies heavily on private philanthropy, as it does not receive government support. amfAR hosts star-studded galas worldwide to raise funds, with events planned in locations such as France, Italy, and the U.S. The organization has raised over $950 million since its founding in 1985, supporting more than 3,900 research grants globally. CEO Kyle Clifford emphasizes the importance of a cure to address stigma and healthcare access issues. 
